Abstract
Idiopathic pulmonary fibrosis (IPF) is a rare and progressive chronic respiratory disease. Although interconnections between gastroesophageal reflux disease (GERD) and IPF are numerous, their relationship is still controversial. Pathogenetic hypotheses involve micro-aspiration of gastric acid causing inflammation and then remodeling of lung structure until fibrosis, even to acute accelerating exacerbations of IPF. Moreover, IPF may itself aggravate GERD increasing intrathoracic pressure. Several studies have evaluated the possible beneficial effects of antacid and antireflux therapies on patients' outcomes and pulmonary function, but results are still conflicting. This narrative review explores many aspects of the relationship between IPF and GERD, including pathogenesis, clinical implications, medical and surgical GERD therapies, summarizing the results of most important studies conducted in this specific field.
| Original language | English |
|---|---|
| Pages (from-to) | 12-19 |
| Number of pages | 8 |
| Journal | Minerva Pneumologica |
| Volume | 59 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Mar 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antireflux therapy
- Gastroesophageal reflux
- Idiopathic pulmonary fibrosis
Fingerprint
Dive into the research topics of 'Idiopathic pulmonary fibrosis and gastroesophageal reflux'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver